A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia
© Adams et al.; licensee BioMed Central Ltd. 2013
Received: 25 April 2012
Accepted: 15 May 2013
Published: 22 May 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|25 Apr 2012||Submitted||Original manuscript|
|16 Aug 2012||Reviewed||Reviewer Report - Felice Iasevoli|
|20 Aug 2012||Reviewed||Reviewer Report - Jason Uslaner|
|24 Aug 2012||Reviewed||Reviewer Report - Wen-Jun Gao|
|30 Aug 2012||Reviewed||Reviewer Report - Bita Moghaddam|
|17 Jan 2013||Author responded||Author comments - Sara Kollack-Walker|
|Resubmission - Version 2|
|17 Jan 2013||Submitted||Manuscript version 2|
|9 Feb 2013||Reviewed||Reviewer Report - Felice Iasevoli|
|12 Feb 2013||Reviewed||Reviewer Report - Jason Uslaner|
|8 May 2013||Author responded||Author comments - Sara Kollack-Walker|
|Resubmission - Version 3|
|8 May 2013||Submitted||Manuscript version 3|
|15 May 2013||Editorially accepted|
|22 May 2013||Article published||10.1186/1471-244X-13-143|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.